Premonitory symptoms in migraine: An electronic diary study

Neurology

Volumn 60, Issue 6, 2003, Pages 935-940

  Giffin, N J ^a   Ruggiero, L ^e   Lipton, R B ^b   Silberstein, S D ^c   Tvedskov, J F ^d   Olesen, J ^d   Altman, J ^e   Goadsby, Peter J ^a   Macrae, A ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; FATIGUE; HEADACHE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MENTAL CONCENTRATION; MIGRAINE; NECK; PREDICTION; PRIORITY JOURNAL; SYMPTOM;

EID: 0037465769     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000052998.58526.A9     Document Type: Article

References (32)

1. Headache Classification Committee of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96.
2. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002;346:257-270.
3. Gowers WR. A manual of diseases of the nervous system. Philadelphia: P. Blakiston, Son & Co, 1888.
4. Russell MB, Rassmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eight-four male and female migraineurs from the general population. Cephalalgia 1996;16:239-245.
5. Waelkens J. Warning symptoms in migraine: characteristics and therapeutic implications. Cephalalgia 1985;5:223-228.
6. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992;12:221-228.
7. Drummond PD, Lance JW. Neurovascular disturbances in headache patients. Clin Exp Neurol 1984;20:93-99.
8. Olesen J, Tfelt-Hansen P, Welch KMA. The headaches. Philadelphia: Lippincott Williams & Wilkins, 2000.
9. Blau JN. Migraine prodromes separated from the aura; complete migraine. BMJ 1980;21:658-660.
10. Amery WK, Waelkens J, Vandenbergh V. Migraine warnings. Headache 1986;26:60-66.
11. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-660.
12. Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017.
13. Harrigan J, Kues J, Ricks D, Smith R. Moods that predict coming migraine headaches. Pain 1984;20:385-296.
14. Spierings E, van Hoof M, Articles R. Fatigue and sleep in chronic headache sufferers: an age- and sex-controlled questionnaire study. Headache 1997;37:549-552.
15. Hannerz J. Symptoms and diseases and smoking habits in female episodic cluster headache and migraine patients. Headache 1997;17:499-500.
16. Pawlikowska T, Chalder T, Hirsch S, et al. Population based study of fatigue and psychological distress. BMJ 1994;308:763-766.
17. Bates D, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993;153:2759-2765.
18. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical utilization among people in the general population who report fatigue. J Gen Intern Med 1993;8:436-440.
19. Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression. Is the association specific to migraine? Neurology 2000;54:308-313.
20. Blau J. Migraine postdromes: symptoms after attacks. Cephalalgia 1991;11:229-231.
21. Isler H-R. Frequency and time course of premonitory phenomena. In: Amery WK, Wauquier A, eds. The prelude to the migraine attack. London: Balliere Tindall, 1986.
22. Spierings EL, Sorbi M, Haimowitz BR, Tellegen B. Changes in daily hassles, mood, and sleep in the 2 days before a migraine headache. Clin J Pain 1996;12:38-42.
23. Luciani R, Carter D, Mannix L, et al. Prevention of migraine during prodrome with naratriptan. Cephalalgia 2000;20:122-126.
24. Matta SGF. Metoclopramide in the treatment of migraine. Practitioner 1974;212:887-890.
25. Waelkens J. Domperidone in the prevention of complete classical migraine. BMJ 1981;284:944.
26. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984;4:85-90.
27. Evers S, Quibeldey F, Grotemeyer KH, Suhr B, Husstedt IW. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999;19:485-491.
28. Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J. Contingent negative variation and headache. Ann Neurol 1986;19:78-80.
29. Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett 1998;257:73-76.
30. Siniatchkin M, Gerber WD, Kropp P, Vein A. How the brain anticipates an attack: a study of neurophysiological periodicity by migraine. Funct Neurol 1999;14:69-77.
31. Afra J, Sandor P, Schoenen J. Habituation of visual and intensity dependence of cortical auditory evoked potentials tend to normalise just before and during migraine attacks. Cephalalgia 2000;20:347.
32. Blin O, Azulay J, Masson G, Aubrespey G, Serratrice G. Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Neuropharmacol 1991;14:91-95.